Altimmune. Every tracked FinTwit mention of $ALT, newest first. 2 mentions since the first on Jan 27, 2026. See the price chart.
March 2026 · 1 mention
Mar 19
Dustin — $ALT
TRUIST has initiated coverage with a Buy rating and a price target of $12,
projecting revenue of $0.6 to $1.0 billion based on just 20,000 patients.
Just 20,000 patient…↗
January 2026 · 1 mention
Jan 27
Dustin — $ALT
5 DAYS IN A ROW HIGHER CLOSING PRICE.
steady price and volume uptick since JPM
Like if you are bullish on $ALT https://t.co/VDoJbSKu7e↗